Liver Neoplasms Clinical Trials

14 recruiting

Liver Neoplasms Trials at a Glance

14 actively recruiting trials for liver neoplasms are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Taipei, San Francisco, and Reno. Lead sponsors running liver neoplasms studies include Boston Scientific Corporation, Eureka Therapeutics Inc., and Academisch Ziekenhuis Maastricht.

Browse liver neoplasms trials by phase

Treatments under study

About Liver Neoplasms Clinical Trials

Looking for clinical trials for Liver Neoplasms? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liver Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liver Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

TheraSphere Japan Pre-Market Study

Liver Neoplasms
Boston Scientific Corporation51 enrolled4 locationsNCT07377487
Recruiting
Phase 1Phase 2

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma+4 more
Pfizer138 enrolled11 locationsNCT07227012
Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Liver NeoplasmsPrimary Liver CancerSecondary Liver Cancer+2 more
HistoSonics, Inc.5,000 enrolled27 locationsNCT06486454
Recruiting

Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room

Liver NeoplasmsInguinal HerniaCholecystitis+1 more
Taipei Veterans General Hospital, Taiwan315 enrolled1 locationNCT07473687
Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting
Phase 2

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Liver Neoplasms
john eisenbrey266 enrolled1 locationNCT06261814
Recruiting
Not Applicable

Spinal Anesthesia For Enhanced Recovery After Liver Surgery

Pain, PostoperativeLiver NeoplasmsHepatectomy
University of Manitoba128 enrolled1 locationNCT03715517
Recruiting

Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

Liver NeoplasmsHepatocellular Carcinoma (HCC)
University of Belgrade15 enrolled1 locationNCT07378709
Recruiting
Phase 2

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

Breast CancerKidney NeoplasmsLiver Neoplasms
UNC Lineberger Comprehensive Cancer Center40 enrolled1 locationNCT07225114
Recruiting
Phase 2

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular CarcinomaCarcinomaLiver Neoplasms+1 more
Yonsei University52 enrolled1 locationNCT07246668
Recruiting
Phase 1Phase 2

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Liver CancerMetastatic Liver CancerLiver Neoplasms+3 more
Eureka Therapeutics Inc.15 enrolled2 locationsNCT04634357
Recruiting
Not Applicable

TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery

Liver CancerLiver MetastasesLiver Neoplasms+1 more
Medical University of Warsaw154 enrolled1 locationNCT06050200
Recruiting
Not Applicable

A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases

Breast NeoplasmsMetastasisLiver Neoplasms
Ruijin Hospital10 enrolled1 locationNCT06567353
Recruiting

Perioperative Energy Expenditure in Major Liver Resection

CancerLiver NeoplasmsLiver Diseases
Academisch Ziekenhuis Maastricht20 enrolled1 locationNCT05931068